Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

PHARMACEUTICALS

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company focused on the commercial development of novel drug formulations and proprietary drug delivery vehicles.  Imprimis believes in the power of the clinical interaction of one patient, one physician and one pharmacist to build new therapies that have broad market appeal.  Drug formulations created by pharmacists and physicians for a specific patient's use are investigated through a proprietary and rigorous evaluation process, the Asset Review Methodology (ARM™), in order to assess safety, efficacy and potential for commercialization. Following sufficient clinical development, the company will use the FDA's 505(b)(2) development pathway, or selectively make its formulations available to the market using alternative commercialization pathways in order to satisfy physician and patient interest in Imprimis' drug assets.  For Imprimis' non-drug assets, such as drug delivery vehicles, Imprimis will seek partnerships with wholesalers in order to make these technologies available to compounding pharmacies across North America.  The company's current focus is in the Ophthalmology, Wound Management, Urology and Pain therapeutic areas.

SAFE HARBOR

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause Imprimis' results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include Imprimis' abi
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  Publicis Groupe customer engagement agency Rosetta ... Healthcare Industry Group Leader, has been featured in the ... inspiring people in the life-sciences industry. Those chosen for ... marketing, technology, creativity, strategy and medicine. ... in its leading Rosetta Consulting practice. In 2012, she ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is pleased ... of the first-of-its-kind comic book available in Canada ... been designed specifically to educate children and their parents about ... affecting more than 300,000 Canadians. Eisai is guided ... (hhc) , in which the patient is central – there ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance ... comic series designed to educate children about the most common ... Medikidz Explain Epilepsy comic series tells a fictional ... navigating middle school while living with epilepsy. ... there is still so much misinformation and lack of awareness ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
(Date:8/21/2014)... 21, 2014 The Mount Sinai Hospital ... called RateMyHospital®, which captures real-time patient feedback and enables ... care. The tool, now available to admitted patients in ... feedback regarding patient satisfaction using smartphones. , "We ... it gives us the timely information we need to ...
(Date:8/21/2014)... to a new market report published by Transparency Market ... Size, Share, Growth, Trends and Forecast, 2013 - 2019," ... 1,531.2 million in 2013 and is expected to grow ... to reach an estimated value of USD 5,246.4 million ... witnessing significant growth due to increasing R&D investment in ...
(Date:8/21/2014)... 2014 Entries are now open for ... comprehensive national awards program totally dedicated to recognizing excellence ... executive leadership. The entry deadline is Oct. 17. , ... Insights™, the first and only national magazine entirely devoted ... , “We launched the HREI Insights Awards program last ...
(Date:8/21/2014)... Greater awareness among parents and providers of the ... full term has decreased the practice in the United ... elective deliveries (EEDs) still occur too frequently. A ... as delivery before 39 weeks without medical or obstetrical ... and offers no benefit to mothers or infants. Leading ...
(Date:8/21/2014)... Stevin McNamara’s original approach to guitar music is ... music that has existed in India for centuries. Literally meaning ... scale or some fixed sequence of notes, but is considered ... appropriate time of day or season of the year — ... musician occurs, in its turn creating an unique “sound manifestation” ...
Breaking Medicine News(10 mins):Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 3Health News:Raga Cycle of Shakti Guitar Follows The Sun 2Health News:Raga Cycle of Shakti Guitar Follows The Sun 3
... Minn. -- Over the past few decades, doctors have ... and base of the tongue. Though oral cancer previously ... tobacco and alcohol use, it,s increasing in younger patients: ... Fortunately, the newer form of cancer tends to be ...
... THURSDAY, March 1 (HealthDay News) -- Teens with chronic fatigue ... as joint and muscle pain, may benefit from an Internet-based ... Researchers in the Netherlands studied teens with the debilitating ... better or had recovered after six months of the Web-based ...
... Grafman, PhD, director of Traumatic Brain Injury Research at Kessler ... Brain Injury Conference on March 6, 2012, in Washington, DC. ... consequences of traumatic brain injury. A well known expert, he ... location of brain injury and genetic polymorphisms on social abilities ...
... of death are linked to unhealthy lifestyle behaviors, ... have lower levels of physical activity and higher ... of Health & Human Services. In a new ... adults who received exercise interventions increased their physical ...
... HealthDay Reporter , WEDNESDAY, Feb. 29 (HealthDay News) ... flu and Parkinson,s disease appears to speed recovery in ... Traumatic brain injury (TBI) victims who weren,t fully conscious ... given amantadine hydrochloride. The drug is already given "off-label" ...
... taken by people with HIV/AIDS but long ago shelved after ... on how the human body uses its natural immunity to ... drugs. In an article published online this month by ... Swiss researchers led by scientists at the University of California, ...
Cached Medicine News:Health News:Mayo Clinic: Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer 2Health News:Web-Based Therapy May Help Teens With Chronic Fatigue 2Health News:Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC 2Health News:Fitness programs for minority adults lack cultural relevance, MU study finds 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 3Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 4Health News:Old drug reveals new tricks 2Health News:Old drug reveals new tricks 3
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
Demineralized cortical fibers and cancellous chips....
... positioning flexibility while permitting the components to be ... transport. The system has a small footprint to ... the same time offers the surgeon total control ... and display of the Stealthstation Treon can be ...
Medicine Products: